Adma Biologics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Adma Biologics
Tip: Access up to 7 years of quarterly data
All positions including Adma Biologics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adma Biologics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $5.7M | 391k | 14.66 |
| 2025-06-30 | $17M | 943k | 18.21 |
| 2025-03-31 | $16M | 817k | 19.84 |
| 2024-12-31 | $8.8M | 512k | 17.15 |
| 2024-09-30 | $10M | 510k | 19.99 |
| 2024-06-30 | $6.0M | 536k | 11.18 |
| 2024-03-31 | $1.4M | 219k | 6.60 |
| 2023-12-31 | $846k | 187k | 4.52 |
| 2023-09-30 | $597k | 167k | 3.58 |
| 2023-06-30 | $457k | 138k | 3.31 |
| 2023-03-31 | $457k | 138k | 3.31 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas